Research Center for Child Mental Development, Chiba University, Chiba, Japan.
Laboratory of Neuropsychology, Institute of Liberal Arts and Science, Kanazawa University, Kanazawa, Japan.
J Med Internet Res. 2021 Dec 13;23(12):e31293. doi: 10.2196/31293.
Cognitive behavioral therapy (CBT) is the gold standard of psychotherapy for psychiatric disorders. However, the format of delivering CBT in person limits access to the intervention. The advancements in information and communication technology, especially the internet, present an opportunity for cognitive behavioral therapists to service patients or clients in remote areas through videoconferencing. Although many randomized controlled trials of videoconference-delivered cognitive behavioral therapy (VCBT) have already been conducted, the overall estimated effect size of VCBT for psychiatric disorders has not been examined by systematic reviews and meta-analyses.
This study attempts to evaluate the effectiveness of VCBT for psychiatric disorders through a systematic and meta-analytic review.
A systematic review and meta-analysis of studies in which VCBT was directly compared to control groups (such as treatment as usual, attention control, wait-list control, and other minimal supports) was carried out. To identify previous studies that meet our study objective, 2 independent reviewers undertook a systematic search through seven databases: MEDLINE (via PubMed), Web of Science, Science Direct, PsycINFO, CINAHL, LILACS, and SciELO. Other databases (ClinicalTrials.gov and Cochrane Central Resister of Controlled Trials) were also checked. All studies included in the review were assessed using the quality criteria of the Cochrane Collaboration. Statistical analysis was performed by using Cochrane Review Manager (RevMan, version 5.4.0). Standardized mean difference was used in major meta-analyses where a P value of .05 or less was the threshold for statistical significance. A heterogeneity test and the chi-square test were performed to assess the presence and extent of statistical heterogeneity with significance set at P<.10. Funnel plots were visually inspected to assess the risk of bias. Subgroup analyses were conducted for each disorder to estimate intervention effects.
The systematic search resulted in 16 studies (total N=1745) that met the criteria for this study and were included in the review. There were 10 studies on depressive symptoms, 3 on chronic pain, 1 on generalized anxiety disorder, 1 on obsessive-compulsive disorder, and 1 on hypochondriasis. The quality and risk of bias was also assessed. Results showed a pooled effect size (Hedge g) post treatment of -0.49 (95% CI -0.68 to -0.29), indicating that VCBT is effective for clients with psychiatric disorders. Study quality did not affect outcomes.
While the overall results indicate the effectiveness of VCBT, there are still only a limited number of studies on specific psychiatric and somatic conditions. Therefore, more randomized controlled trials are needed to establish the effectiveness of VCBT for different disorders.
International Prospective Register of Systematic Reviews (PROSPERO) CRD42021224832; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=224832.
认知行为疗法(CBT)是精神障碍心理治疗的金标准。然而,当面提供 CBT 的形式限制了干预措施的可及性。信息和通信技术的进步,尤其是互联网,为认知行为治疗师通过视频会议为远程地区的患者或客户提供服务提供了机会。尽管已经进行了许多关于通过视频会议提供的认知行为疗法(VCBT)的随机对照试验,但系统评价和荟萃分析尚未评估 VCBT 治疗精神障碍的总体估计效果。
本研究试图通过系统评价和荟萃分析评估 VCBT 治疗精神障碍的效果。
对直接将 VCBT 与对照组(如常规治疗、注意对照、等待名单对照和其他最小支持)进行比较的研究进行了系统评价和荟萃分析。为了确定符合我们研究目标的先前研究,2 位独立评审员通过 7 个数据库进行了系统搜索:MEDLINE(通过 PubMed)、Web of Science、Science Direct、PsycINFO、CINAHL、LILACS 和 SciELO。还检查了其他数据库(ClinicalTrials.gov 和 Cochrane 中央对照试验注册中心)。对纳入研究的质量标准进行了评估,使用 Cochrane 协作组的质量标准。统计分析使用 Cochrane Review Manager(RevMan,版本 5.4.0)进行。主要荟萃分析中使用标准化均数差,如果 P 值<.05,则表示具有统计学意义。进行了异质性检验和卡方检验,以评估存在和程度的统计学异质性,并设定 P 值<.10 为显著性水平。通过视觉检查漏斗图来评估偏倚风险。对每种疾病进行了亚组分析,以估计干预效果。
系统搜索共产生了 16 项研究(总 N=1745),符合本研究的标准,并纳入了本研究。其中 10 项研究为抑郁症状,3 项为慢性疼痛,1 项为广泛性焦虑症,1 项为强迫症,1 项为疑病症。还评估了质量和偏倚风险。结果显示,治疗后合并效应量(Hedge g)为-0.49(95%CI-0.68 至-0.29),表明 VCBT 对精神障碍患者有效。研究质量并不影响结果。
虽然总体结果表明 VCBT 是有效的,但针对特定精神和躯体疾病的研究仍然有限。因此,需要更多的随机对照试验来确定 VCBT 对不同疾病的有效性。
国际前瞻性系统评价注册系统(PROSPERO)CRD42021224832;https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=224832。